Introduction
The neuropeptides bombesin and endothelin-1 (ET-1) have been implicated in cell migration in numerous malignancies including colon cancer, neuroblastoma, ovarian cancer and transitional cell carcinoma (Aprikian et al., 1997; Lummen et al., 1997; Rosano et al., 2001; Saurin et al., 2002) . Bombesin and ET-1 stimulate seven-transmembrane GTP-binding proteins (G-protein)-coupled receptors (GPCRs). Bombesin stimulates the BB1-4 GPCRs and ET-1 stimulates the ETA and ETB GPCRs (Grant et al., 2003) . We and others have reported that the neuropeptides bombesin and ET-1 stimulate prostate cancer (PC) cell migration and invasion (Aprikian et al., 1997; Shen et al., 2000; Fukuhara et al., 2001; Sumitomo et al., 2005) . Although various signaling pathways have been implicated in bombesin-stimulated cell motility, the signaling cascade used by bombesin and ET-1 to stimulate PC cell migration are not well delineated. Defining this pathway would potentially provide targets to pharmacologically manipulate PC cells ability to invade. In this regard, we have previously demonstrated that bombesin and ET-1 effects are inhibited by neutral endopeptidase (NEP), a cell-surface peptidase normally expressed by prostatic epithelial cells but whose expression is lost in a B50% of PCs. Neutral endopeptidase catalytically inactivates bombesin and ET-1. Loss of NEP facilitates neuropeptides-mediated cell migration, which can be inhibited by re-expression of NEP at the cell surface .
The Rho subfamily of Ras monomeric GTPases function to regulate a diverse array of extracellular stimuli. Rho GTPase activation is facilitated by multiple regulatory proteins, in particular guanine nucleotide exchange factors (GEFs) such as Dbl family proteins. Once activated, Rho GTPases interact with and regulate a variety of diverse downstream effectors, and initiate a network of cytoplasmic and nuclear signaling cascades (Karnoub et al., 2004) . RhoA is a member of the Rho GTPases that regulates fundamental cell processes, including cytoskeletal reorganization (Etienne-Manneville and and adhesion (Braga, 2000) . RhoA is required for normal migration in a variety of cells including neutrophils, monocytes and fibroblasts. RhoA, like other GTPases, cycles between a GTPbound active form and a GDP-bound inactive form. Guanine nucleotide exchange factors activate RhoA by catalysing the release of GDP in exchange for GTP. GTPase-activating proteins (GAPs) inhibit RhoA by catalysing the hydrolysis of GTP to GDP (Bourne et al., 1990) .
Endothelin-1 (Sugden, 2003) and bombesin (Saurin et al., 2002) receptors can activate RhoA, suggesting that RhoA-signaling pathways may be required for neuropeptide-stimulated migration in cancer cells. Bombesin and ET-1 receptors activate RhoA through the heterotrimeric G-protein a-subunits Ga 13 (Hersch et al., 2004) and Ga 13 /Gaq (Mao et al., 1998; Yuan et al., 2001) , respectively. There is a small subfamily of Dbl RhoGEFs whose members bind and serve as effectors for heterotrimeric G-protein a-subunits. This subfamily of RhoGEFs consists of Lsc/p115 RhoGEF (Glaven et al., 1996; Hart et al., 1996 Hart et al., , 1998 Whitehead et al., 1996; Kozasa et al., 1998) , PDZ-RhoGEF (Rholike GEF containing a PDZ (PSD-95/Disc-large/ZO-1) domain/GTRAP-48 (Fukuhara et al., 1999) , and leukemia-associated RhoGEF (LARG) (Fukuhara et al., 2000; Reuther et al., 2001) . These RhoGEFs can bind Ga 12/13 through a regulator of G-protein signaling (RGS)-like domain in their N-terminus. Leukemiaassociated RhoGEF can also bind Ga q . This suggests that one or more members of this subfamily of Gprotein a-subunit-associated RhoGEFs may link these neuropeptide receptors to RhoA. In the current report, we analysed the signaling cascade involved in bombesin and ET-1 mediated PC cell motility. Here, we demonstrate that bombesin stimulates PC cell migration through a signaling network that requires the heterotrimeric G-protein Ga 13 subunit, and the RhoA effector Rho-associated coiled-coil forming protein kinase (ROCK). We show that PDZ-RhoGEF and LARG link bombesin receptors to RhoA in a non-redundant manner in PC cells. We also show that focal adhesion kinase (FAK), which activates PDZ-RhoGEF and LARG, is required for normal bombesin-stimulated RhoA activation in prostate cells, and NEP inhibits neuropeptide activation of RhoA in PC cells.
Results
Bombesin and endothelin-1 stimulate RhoA activation and cytoskeletal reorganization in prostate cancer cell We previously reported that bombesin and ET-1 stimulate migration of PC cells Sumitomo et al., 2001) . In other cell types, migration stimulated by ET-1 (Tangkijvanich et al., 2001 ) and bombesin (Saurin et al., 2002) requires RhoA. To determine if bombesin and ET-1 stimulate RhoA activation in PC cells, we measured RhoA activity in PC-3 cells incubated with vehicle (phosphate-bufffered saline (PBS)) or one of the two neuropeptides. Both bombesin (10 nM; Figure 1A ) and ET-1 (10 nM; Figure 1B ) maximally stimulate RhoA activation in PC-3 cells 10-15 min following the addition of neuropeptide.
RhoA-signaling pathways regulate fundamental cellular functions, including cytoskeletal reorganization, transcription and apoptosis (Van Aelst and D'SouzaSchorey, 1997; Mackay and Hall, 1998; EtienneManneville and Hall, 2002) . Activated RhoA stimulates reorganization of the cytoskeleton to form actin stress fibers in many cell types (Ridley and Hall, 1992; Hall, 1998) . To determine if bombesin or ET-1 stimulate cytoskeletal reorganization in PC cells, we visualized actin stress fibers in PC-3 cells incubated with bombesin, ET-1 or vehicle. As shown in Figure 1C (panel a), unstimulated PC-3 cells displayed few actin stress fibers. Bombesin (10 nM; panel c) and ET-1 (10 nM; panel e) stimulated actin stress fiber formation in PC-3 cells. The Rho-associated coiled-coil forming protein kinases p160ROCK/ROCK-1 (Ishizaki et al., 1996 and ROCK-a/ROCK-2 (Leung et al., 1996; Matsui et al., 1996) are direct downstream effectors of RhoA that regulate actin stress fiber formation. They are specifically inhibited by the synthetic pyridine derivative, Y-27632 (Uehata et al., 1997; Ishizaki et al., 2000) . Pretreatment of PC-3 cells for 60 min with 10 mM Y-27632 abolished actin stress fiber formation stimulated by bombesin (panel d)) and ET-1 (panel f), demonstrating that bombesin and ET-1 stimulate the RhoA effector, ROCK, to direct cytoskeletal reorganization.
Rho-associated coiled-coil forming protein kinase and Ga 13 are required for bombesin and endothelin-1 mediated RhoA activation and prostate cancer cell migration Bombesin and ET-1 have no direct effect on the PC-3 cell growth (Nagakawa et al., 1998 (Nagakawa et al., , 2001 ), but stimulate PC-3 cell migration. We therefore used a wound closure assay to determine if ROCK is required for neuropeptide-mediated PC cell migration. We compared migration of PC-3 cells stimulated with bombesin in the presence and absence of 10 mM Y-27632. As illustrated in Figure 2a , bombesin (10 nM) significantly stimulated PC-3 cells to migrate faster than cells incubated with PBS alone as control with the wound width decreased in bombesin-treated cells to 50.6% of that in PBS treatment. This effect was abrogated by co-incubation with Y-227632 with the wound width increased to 114.4% of that in PBS treatment. Y-27632 similarly inhibited ET-1-induced migration in PC-3 cells (data not shown). These results demonstrate that bombesin-and ET-1-stimulated PC cell migration requires ROCK.
Previous studies indicate that endothelin A (Gohla et al., 1999; Hersch et al., 2004) , endothelin B (Kitamura et al., 1999; Liu and Wu, 2003) , and bombesin receptors activate heterotrimeric G-protein subunits, which includes Ga 12 and Ga 13 (Yuan et al., 2001) . Activated Ga 12/13 in turn binds to and activate rhoGEFs Suzuki et al., 2003) , which then activate RhoA (Dhanasekaran and Dermott, 1996; Kurose, 2003) . Ga 13 has been directly implicated in GPCRstimulated cell migration (Offermanns et al., 1997; Radhika et al., 2004) . Therefore, we considered that the Ga 13 subunit may couple bombesin and ET-1 receptors to RhoA in PC cells. Using a dominant-negative mutant form of Ga 13 to disrupt the interaction between GPCRs and endogenous Ga 13 (Sugimoto et al., 2003) , we measured RhoA activation in PC-3 cells transiently transfected with either an empty vector (pCAGGS) or an expression vector encoding a peptide fragment corresponding to the C-terminal 57 amino acid (aa) of Ga 13 (Ga 13 aa 321-377) that exerts a dominant-negative effect on endogenous Ga 13 signaling (Yuan et al., 2001; Arai et al., 2003; Sugimoto et al., 2003; Xu et al., 2003) . Transfected cells were incubated with vehicle (PBS), ET-1 (10 nM) or bombesin (10 nM) for 10 min. As shown in Figure 2b (left panel), RhoA activation occurred in control cells but not in cells expressing the C-terminus of Ga 13 (Ga 13 -CT). Western blotting using an Ab to the myc-epitope-tagged dominant-negative Ga 13 -CT confirmed expression of the mutant protein (Figure 2b , right panel). We next determined if Ga 13 was necessary for neuropeptide-stimulated PC cell migration. Bombesin-stimulated cell migration was significantly inhibited in PC-3 cells transfected with Ga 13 -CT compared to pCAGGS-transfected control cells with the wound width increasing from 52.5 to 76.2% (Figure 2c ). Together, these data suggest that Ga 13 is required for bombesin and ET-1 to stimulate RhoA activation and cell migration in PC-3 cells.
Focal adhesion kinase is necessary for bombesin and endothelin-1 mediated RhoA activation We previously reported that activation of FAK by bombesin and ET-1 is necessary for neuropeptide- Neuropeptide-stimulated cell migration in prostate cancer R Zheng et al stimulated migration in PC cells . It has recently been reported that the Ga 13 subunit of GPCRs activates FAK, and that FAK phosphorylates and activates the rhoGEFs PDZRhoGEF and LARG, but not p115 RhoGEF (Chikumi et al., 2002) . Thus, to determine if FAK is required for ET-1-and bombesin-stimulated RhoA activation, we compared RhoA activation in PC-3 cells that did or did not express the non-catalytic C-terminus of FAK, FAK-related non-kinase (FRNK). FAK-related non-kinase has a dominant-negative action on FAK function because it inhibits localization of FAK to focal adhesions and FAK phosphorylation (Richardson and Parsons, 1996) . FAK-related non-kinase expression substantially reduced both bombesin and ET-1-stimulated RhoA activation ( Figure 2d ). These data show that FAK inhibition significantly decreases bombesin-and ET-1-stimulated RhoA activation.
Two non-redundant Rho guanine nucleotide exchange factors couple bombesin receptors to RhoA in prostate cancer cells Our studies indicated that bombesin and ET-1 activate the Ga 13 subunit of their respective GPCRs, resulting in RhoA activation and leading to PC cell migration. This suggested that one or more of the G-subunit-associated RhoGEFs couples bombesin receptors to RhoA. We first used reverse transcriptase-polymerase chain reaction to determine if the three known Ga-subunitassociated RhoGEFs are expressed in PC-3 cells. Using primers that span at least one intron (Table 1) , we demonstrated that p115 RhoGEF, PDZ-RhoGEF and LARG are all expressed in PC-3 cells ( Figure 3a ). Transcripts for Vav1, a RhoGEF restricted to hematologic cells, were not detected in PC-3 cells. To determine if one or more of these RhoGEFs is required for bombesin receptors to activate RhoA, we compared bombesin-stimulated RhoA activation in PC-3 cells transiently transfected with siRNA duplexes to suppress these RhoGEFs. The siRNA sequences were generated based on previous RNA oligonucleotides that effectively and specifically suppress expression of these RhoGEFs (Wang et al., 2004a, b) . As shown in Figure 3b , Western blotting demonstrated that siRNA duplexes for p115 RhoGEF, PDZ-RhoGEF and LARG-suppressed RhoGEF expression in PC-3 cells (p115 RhoGEF and LARG reduced by B95%; PDZ-RhoGEF reduced by B65%). Suppression of PDZ-RhoGEF and LARG expression reduced bombesin-stimulated RhoA activation by approximately 85% and 35%, respectively, whereas suppression of p115 RhoGEF expression only minimally inhibited (B25%) RhoA activation (Figure 3c ). Suppression of PDZRhoGEF and LARG independently reduced RhoA activation, suggesting non-redundant roles. These data demonstrate that bombesin receptors activate RhoA in PC cells by specifically coupling to two non-redundant G-protein-a subunit-associated RhoGEFs, PDZ-Rho-GEF and LARG.
Neutral endopeptidase inhibits bombesin and endothelin-1-stimulated RhoA activation Neutral endopeptidase is a 90-110 kDa transmembrane protein with an extracellular peptidase domain with a variety of peptide substrates including bombesin and ET-1 (Shipp and Look, 1993) . Neutral endopeptidase is expressed on the surface of benign prostate epithelial cells and the loss of NEP contributes to PC progression (Papandreou et al., 1998) . Neutral endopeptidase expression is absent in PC-3 and TSU-Pr1 cells, but is present in LNCaP cells (Papandreou et al., 1998) . We previously reported that NEP effectively inhibits PC migration through both catalytic and non-catalytic mechanisms , therefore we examined the effects of NEP on bombesin-and ET-1-stimulated RhoA activation. WT-5 cells are derived from TSU-Pr1 cells and express NEP following tetracycline removal (Papandreou et al., 1998) . Withdrawal of tetracycline from WT-5 cells upregulated NEP expression and blocked bombesin-and ET-1-stimulated RhoA activation ( Figure 4a ). In contrast, the lipid agonist lysophosphatidic acid (LPA)-induced RhoA activation and was not affected by NEP expression (Figure 4a ). Next we used the specific NEP protease inhibitor CGS24592 (De Lombaert et al., 1994) CGS24592 alone had no effect on RhoA activation in LNCaP cells (data not shown). Together, these results demonstrate that the catalytic activity of NEP inhibits bombesin-and ET-1-stimulated RhoA activation in PC cells.
Discussion
Cell motility is essential for neoplastic progression (Kassis et al., 2001 ). We and others have shown that the neuropeptides bombesin and ET-1 stimulate PC cell migration and invasion (Aprikian et al., 1997; Shen et al., 2000; Kajiyama et al., 2005) . Here, we have demonstrated that (i) bombesin and ET-1 stimulate RhoA activation and stress fiber formation; (ii) NEP proteolytically inhibits bombesin and ET-1-stimulated RhoA activation; (iii) Ga 13 and the RhoA effector, ROCK, are required for bombesin-and ET-1-stimulated PC cell migration; (iv) FAK is required for bombesinstimulated RhoA activation; and (v) PDZ-RhoGEF and LARG link bombesin receptors to RhoA. Based on these results and our previous work , we have generated a model for bombesin signaling in PC cells ( Figure 5 ). Our results validate many parts of this model for neuropeptides signaling.
RhoA is a monomeric GTPase that is required for migration in several cell types including neutrophils (Xu et al., 2003) , monocytes (Worthylake et al., 2001 ) and fibroblasts (Sander et al., 1999) . We have demonstrated that bombesin and ET-1 activate RhoA and that the RhoA effector, ROCK, is required for bombesinstimulated migration of PC cells. Prior work demonstrated that ROCK is required for PC cell migration stimulated by the growth factor epidermal growth factor or bone marrow fibroblast-conditioned media (Somlyo et al., 2000) . Together, these results indicate that both neuropeptides that activate GPCRs and growth factors that activate receptor tyrosine kinases require RhoA and ROCK to induce PC cell migration.
We have also demonstrated that bombesin receptors signal through Ga 13 to stimulate PC cell migration (Figure 2c ). The Ga 12 class of heterotrimeric G-protein a-subunits, which consists of Ga 12 and Ga 13 , were cloned by homology to previously identified mammalian a-subunits (Strathmann and Simon, 1991) . Ga 12 and Ga 13 have a diverse group of effectors, including RhoA (Dhanasekaran and Dermott, 1996; Kurose, 2003) . Ga 13 was first implicated in GPCR-stimulated cell migration because Ga 13 null murine embryonic fibroblasts have impaired chemokinesis to thrombin (Offermanns et al., 1997) . Recent work indicates that Ga 13 regulates cell migration by forming a complex with the cortactininteracting protein Hax-1, cortactin and Rac1 (Radhika et al., 2004) . This has particular relevance to neoplastic progression because Hax-1 is upregulated in a hypoxic tumor environment (Jiang et al., 2003) .
There are more than 60 Dbl-RhoGEF genes in the human genome (Schmidt and Hall, 2002) , and approximately three times the number of Rho GTPase genes (Burridge and Wennerberg, 2004) . In addition to their conserved tandem DH and PH domains, Dbl RhoGEFs contain a diverse array of conserved functional domains, including intermolecular interaction and catalytic domains. The excess of RhoGEFs compared to Rho (Zhao et al., 1997) . In contrast, the bombesin receptor couples to both PDZRhoGEF and LARG, while none of the three receptors appears to couple to p115 RhoGEF. These results provide additional evidence for the specificity of the surface receptor-RhoGEF interaction. It is notable that bombesin activation of RhoA requires both PDZRhoGEF and LARG. This indicates they are not redundant. There are several possible explanations for this. First, PDZ-RhoGEF and LARG could couple to different G-protein a-subunits. Bombesin receptors couple to Ga 12/13 and Ga q (Yuan et al., 2001; Rozengurt, 2002) . PDZ-RhoGEF couples to Ga 12 and Ga 13 , while LARG couples to Ga 12 , Ga 13 and Ga q . This could explain why PDZ-RhoGEF cannot compensate for LARG, but is not sufficient to explain the converse. Second, the two RhoGEFs may couple to different bombesin receptors. There are at least four bombesin receptors (Nakagawa et al., 2005) . They have different affinities for bombesin-related peptides (Nakagawa et al., 2005) . The two RhoGEFs could couple to distinct receptors. Finally, the two RhoGEFs may activate RhoA in a dose-dependent manner, requiring normal expression of both for full activation.
Another RhoGEF, Vav3, has recently been implicated in PC, specifically transcriptional activation of the androgen receptor in LNCaP cells (Lyons and Burnstein, 2005) . Levels of Vav3 increase during progression to androgen independence in LNCaP cells resulting in continued AR signaling (even under conditions of low androgen). Presumably, other RhoGEFs are also critical to PC development and progression. Figure 2 Rho-associated coiled-coil forming protein kinase (ROCK), Ga 13 and focal adhesion kinase (FAK) are required for bombesin-stimulated RhoA activation and prostate cancer (PC) cell migration. (a) PC-3 cell monolayers were scraped with a sterile pipette tip and then maintained in serum-free media for 24 h with either PBS (control), 10 nM bombesin, 10 nM bombesin with 10 mM Y-27632 or 10 mM Y-27632 alone. Cell migration spread was measured according to wound closure distance, and quantitation of wound closure was determined as described in Materials and methods. Data are presented as the mean wound width after 24 h stimulation with bombesin/initial wound width7s.e.m. derived from two independent experiments. Bombesin-stimulated migration is inhibited by Y-27632 (*, Po0.05). (b) (Left) Western blots of activated and total RhoA in lysates derived from PC-3 PC cells transiently transfected with an empty vector or a vector expressing a dominant-negative mutant form of Ga 13 (Ga 13 -CT) and incubated with PBS (control), 10 nM bombesin, or 10 nM endothelin-1 (ET-1) for 10 min. Blots are representative of two independent experiments with similar results. The dominant-negative form of Ga 13 inhibits bombesin-stimulated RhoA activation in PC-3 cells. (Right), Western blot of the myc-epitope in lysates of PC-3 cells transfected with empty vector (pCAGGS) or a vector expressing a myc-epitope tagged dominant-negative mutant form of Ga 13 (Ga 13 -CT). The dominant-negative mutant form of Ga 13 is expressed in transfected PC-3 PC cells. (c) (Upper) Photomicrographs ( Â 4 objective) of monolayers of PC-3 cells that were transiently transfected with no vector or a vector expressing a dominant-negative mutant form of Ga 13 (Ga 13 -CT) disrupted with the tip of a sterile pipette to create a uniform wound, and then maintained in serum-free media for 24 h with either PBS (control) or 10 nM bombesin as indicated. The dominant-negative form of Ga 13 inhibits bombesinstimulated PC-3 cell migration. pGFP-C1 plasmid was used as a transfection control to ensure the cell transfection efficiency was >90%. Photomicrographs are representative of three independent experiments. (Lower)Quantitation of wound closure in PC-3 cells after stimulation with 10 nM bombesin. Data presented are the mean wound width after 24 h stimulation with bombesin/initial wound width7s.e.m. derived from three independent experiments. Bombesin-stimulated migration is decreased in PC-3 cells transfected with dominant-negative Ga 13 (#, Po0.05). Neuropeptide-stimulated cell migration in prostate cancer R Zheng et al
We have also established that FAK is required for ET-1 and bombesin-stimulated activation of RhoA. Previous work demonstrates that FAK can be activated by GPCRs, Ga 12 and Ga 13 (Chikumi et al., 2002) . Initial published results suggested that downstream of GPCRs, FAK was an effector of RhoA (Rankin et al., 1994) . However, evidence has now emerged that demonstrates FAK may be both an activator and effector of RhoA, downstream of GPCRs (Chikumi et al., 2002) . Our results provide evidence that FAK can activate RhoA downstream of the bombesin and ET-1 GPCR receptors. Previous work demonstrated that FAK can stimulate the GEF activity of PDZ-RhoGEF and LARG by phosphorylating tyrosine residues in their RGS domains (Chikumi et al., 2002) . It is possible that FAK activates RhoA in PC cells by phosphorylating and activating these two RhoGEFS.
In summary, we demonstrate that Ga 13 , FAK, PDZRhoGEF, LARG, RhoA and ROCK are downstream effectors of neuropeptide signaling in PC cells. This establishes a contiguous signaling pathway from the bombesin receptor to ROCK and implicates NEP as a major regulator of RhoA activity in PC cells. Moreover, these studies identify signaling intermediates as potential targets for rational pharmacologic manipulation of neuropeptide signaling in PC cells. . These chemicals were used as previously described (Papandreou et al., 1998; Dai et al., 2001; Iwase et al., 2004) .
Materials and methods

Antibodies and reagents
Cell culture and reagents PC-3 and LNCaP cells were maintained in RPMI 1640 medium supplemented with 2 mM glutamine, 1% nonessential amino acids, 100 U/ml streptomycin and penicillin containing 10% fetal calf serum (FCS). WT-5 cells stably expressing wildtype NEP under the control of a tetracycline-repressed promoter were constructed as described previously (Papandreou et al., 1998; Iwase et al., 2004) . WT-5 cells were maintained in RPMI 1640 medium supplemented with 0.5 mg/ ml G-418, 150 mg/ml hygromycin and 1 mg/ml tetracycline. For NEP induction, WT-5 cells were washed with PBS three times and then incubated in RPMI 1640 medium containing 10% tetracycline-free FCS. After 48 h incubation, the cells were serum starved for 24 h, and then treated with 10 nM bombesin or ET-1 for 10 min.
Transient transfection PC-3 cells were transiently transfected with mammalian expression vectors encoding FRNK, the dominant-negative mutant form of FAK (kindly provided by Dr Filippo Giancotti) or Ga 13 -CT, the dominant-negative mutant form of Ga 13 (Suzuki et al., 2003) using Lipofectamine (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's recommendations. Cytomegalovirus promoter driven pGFP-C1 plasmid (CLONTECH, CA, USA) was used as a transfection control to evaluate the transfection efficiency. After recovery in medium containing FCS for 24 h, the cells were serum starved for 24 h, and then treated with 10 nM bombesin or ET-1 for 10 min.
Rho-activation assay Activated RhoA was detected using a commercially available pull-down assay kit for Rho-GTP bound to a recombinant form of the Rho-binding domain (RBD) of Rhotekin (Upstate Biotechnology, Lake Placid, NY, USA). Briefly PC-3 cells treated with or without stimulation by LPA, ET-1 or bombesin for 5-30 min after serum starvation for 24 h were lysed in 1 Â Mg 2 þ lysis/wash buffer, and equal volumes of lysate were incubated with 30 ml GST-rhotekin RBD beads at 41C for 45 min. The beads were washed three times with RIPA buffer. Bound Rho was eluted by boiling in 2 Â sample buffer. Activated RhoA bound to beads and total RhoA in cell lysates were detected by immunoblotting using anti-RhoA Ab, according to the manufacturer's instructions.
Sodium dodecylsulfate-polyacrylamide gel electrophoresis and immunoblotting Immunoblots were developed with the ECL Plus Detection System (Amersham) on Kodak photographic film. Band densities were measured using ImageJ software (NIH; http:// rsb.info.nih.gov/ij/) and are presented as the mean7s.e.m. of at least n ¼ 2 independent experiments.
Immunofluorescence microscopy PC-3 cells were cultured in serum-free media for 24 h, incubated with or without the indicated agonist, fixed in 3.7% formaldehyde in PBS, permeabilized with 0.2% triton X-100 in PBS for 10 min, incubated in PBS containing 1% bovine serum albumin (BSA) and 5% skim milk for 30 min, and finally labeled with rhodamine-conjugated phalloidin (R-415; Molecular Probes, Eugene, OR, USA) for 1 h. Images were obtained with an Axiovert 35 fluorescent microscope (Carl Zeiss Microimaging, Thornwood, NY, USA), using a Â 40 objective and a 594 nm filter.
Wound-closure assay PC-3 cells were cultured in six-well plates for 24 h overnight, and then refed with RPMI 1640 medium containing 0.1% BSA for 24 h resulting in monolayers more than 90% confluent. Wounds of 600-700 mm were generated by scraping the cell monolayers with a 200 ml pipet tip (USA Scientific, Ocala, FL, USA) across the diameter of the well. Wounded monolayers were incubated for 24 h in serum-free medium with either vehicle, bombesin or bombesin with Y-27632. Images were collected with a PVC 100C CCD camera (Pixera, Los Gatos, CA, USA) mounted on a TMS microscope with a Â 4 objective (Nikon, Melville, NY, USA) using Studio 2.0 software (Pixera). Image dimensions were converted from pixels to micrometers using a calibration image. The mean width for each wound was calculated from width of the wound at three locations in the wound. Data are presented as the mean7s.e.m. percentage of the wound width at 0 h. Photomicrographs are representative of three independent experiments.
Reverse transcriptase-polymerase chain reaction analysis Total RNA was isolated from cells using TRIzol reagent (Invitrogen), reverse transcribed using random hexamers (BD Biosciences, San Jose, CA, USA), and polymerase chain reaction (25 cycles) was performed using the appropriate primers (Table 1) at the indicated annealing temperatures in a PTC-100 thermocycler (MJ Research, Watertown, MA, USA). Amplicons were then subjected to agarose gel electrophoresis.
Transfection of siRNAs into PC-3 cells Double-stranded RNA duplexes targeting the sequences corresponding to the RGS domains of p115-RhoGEF (5 0 -CATACCATCTCTACCGACG-3 0 ), PDZ-RhoGEF (5 0 -ACT-GAAGTCTCGGCCAGCT-3 0 ), and LARG (5-GAAACTCG TCGCATCTTCC-3 0 ) were generated by annealing 21-nt sense and antisense oligonucleotides containing 3 0 TT overhangs. The oligonucleotides were designed based on previously published methods (Wang et al., 2004a, b) and synthesized by Dharmacon (Boulder, CO, USA). Complementary oligonucleotide pairs were resuspended at 0.3 mg/ml in annealing buffer (100 mM potassium acetate, 30 mM N-2-hydroxyethylpiperazine-N 0 -2-ethanesulfonic acid (HEPES)-KOH, 2 mM magnesium acetate, pH 7.4), heated to 901C for 1 min, and then allowed to anneal at 371C for 1 h. PC-3 cells were transiently transfected in a 10 cm plate with 100 nM (final concentration) of the RhoGEF siRNA duplexes and 20 ml of Dharmafect reagent (Dharmacon) in a total of 10 ml of serumfree transfection medium. After 48 h, protein lysates were prepared for Rho activation assay as described above. Negative control is non-target siRNA 1# (Dharmacon, Boulder, CO, USA). A portion of these lysates was subjected to Western blotting to determine the level of RhoGEF expression in order to calculate the efficiency siRNA uppression of RhoGEF expression.
Data analysis and statistics
Data are presented as the mean7s.e.m. of at least n ¼ 2 independent experiments. Statistical and graphic analyses were done using GraphPad Prism 4.0 software (San Diego, CA, USA).
Abbreviations NEP, neutral endopeptidase 24.11; ET-1, endothelin-1; PC, prostate cancer; FAK, focal adhesion kinase; GEFs, guanine nucleotide exchange factors; GAPs, GTPase-activating proteins; GPCRs, G-protein-coupled receptors; G-protein, GTPbinding proteins; RGS, regulator of G-protein signaling; LARG, leukemia-associated RhoGEF; LPA, lysophosphatidic acid.
